Current Opinion in Lipidology
- Atherosclerosis: cell biology and lipoproteins
- Triglycerides as target of cardiovascular risk reduction
- Deep dive to the secrets of the PREDIMED trial
- The COVID-19 pandemic: lifestyle and cardiovascular risk factors
- Impact drugs targeting cardiometabolic risk on the gut microbiota
- Impact of metabolic dysfunction on cognition in humans
- Impact of ultra-processed food consumption on metabolic health
- The role of the molecular circadian clock in human energy homeostasis
- Liver fat storage pathways: methodologies and dietary effects
- Mendelian randomization as a tool for causal inference in human nutrition and metabolism
- Editorial introductions
- Cardiovascular risk in patients with nonalcoholic fatty liver disease: looking at the liver to shield the heart
- The fish-oil paradox
- ATP-citrate lyase: a driver of metabolism and histone acetylation
- Proprotein convertase subtilisin/kexin type 9 inhibition as the next statin?
- Advances, gaps and opportunities in the detection of familial hypercholesterolemia: overview of current and future screening and detection methods
- Hypertriglyceridemia: new approaches in management and treatment
- Targeting epigenetics as atherosclerosis treatment: an updated view
- Changing dietary approaches to prevent cardiovascular disease
- The interconnection between lipoprotein(a), lipoprotein(a) cholesterol and true LDL-cholesterol in the diagnosis of familial hypercholesterolemia